by Noah Green CPA CFE | May 24, 2026 | Case Studies, Daily DD
The Patient Care America settlement is a practical False Claims Act diligence case for PE-backed healthcare platforms: marketing economics, commission payments, and investor approvals can become central when claims are allegedly generated through kickbacks. This case...
by Noah Green CPA CFE | May 24, 2026 | Case Studies, False Claims Act
Not legal advice. This article is educational. Cases are described according to their public posture. Civil settlements resolve allegations without an admission of liability, and complaint-only matters are described as allegations. The government just changed who it...
by Noah Green CPA CFE | May 23, 2026 | Case Studies, Daily DD
The Markovich prosecution shows why addiction-treatment buyers cannot stop at payer contracts and utilization reports. Patient recruitment, inducements, churn, lab economics, and service delivery all have to be tested before the wire. By Noah Green CPA CFE This...
by Noah Green CPA CFE | May 22, 2026 | Case Studies, Daily DD
Behavioral-health and addiction-treatment buyers cannot underwrite Medicaid revenue from billing reports alone. The Arizona AHCCCS matter shows what happens when patient acquisition, service delivery, and documentation are not tested before the wire. By Noah Green CPA...
by Noah Green CPA CFE | May 21, 2026 | Case Studies, Daily DD
Cerebral’s non-prosecution agreement shows that buyer risk can exist even without a corporate indictment when internal business practices affect controlled-substance prescribing. The resolution is a template for how enforcement agencies read telehealth operating...
by Noah Green CPA CFE | May 20, 2026 | Case Studies, Daily DD
Telehealth buyers cannot treat prescription volume, prior authorizations, and patient growth as clean SaaS-style metrics. The Done case shows how a controlled-substance platform’s commercial model, clinical workflow, and claims process can become the core of a...
